B58.09
Other toxoplasma oculopathy
Clinical Classification Guidelines
Inclusion Terms
- Toxoplasma uveitis
Medical Intelligence & Overview
Toxoplasma oculopathy, coded as B58.09 in the ICD-10 classification, refers to eye conditions caused by infection with the parasite Toxoplasma gondii. This parasitic infection can lead to inflammation inside the eye, particularly affecting the retina and other ocular structures. Known commonly as toxoplasma uveitis, this condition is one of the most prevalent causes of infectious uveitis worldwide. Recognizing and understanding this condition is essential for early diagnosis and management to prevent potential vision loss.
Causes & Symptoms
Clinical Causes: Primary infection with Toxoplasma gondii, often contracted through contaminated food or water. Transmission through undercooked or raw meat containing tissue cysts. Ingestion of oocysts shed in cat feces, especially in contaminated soil or water. Congenital transmission from mother to baby during pregnancy. Reactivation of dormant parasites in the retina, particularly in immunocompromised individuals.
Key Symptoms: Floaters in the vision, appearing as small shapes drifting across the visual field. Blurred vision or decrease in visual acuity. Eye redness and mild to moderate pain. Photophobia or sensitivity to light. In some cases, visibility of a focal lesion or scar on the retina. In severe instances, visual field defects or permanent vision impairment.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of toxoplasma oculopathy involves a combination of clinical evaluation and investigative procedures. Eye examinations may reveal characteristic retinal lesions, often with a focal necrotizing chorioretinitis. Diagnostic tests include blood tests for antibodies against Toxoplasma gondii, such as IgG and IgM, to determine recent or past infection. Ocular imaging techniques like optical coherence tomography (OCT) or fluorescein angiography can help assess the extent of retinal involvement. In some cases, intraocular fluid samples may be obtained for laboratory analysis to confirm the presence of the parasite.
Treatment Protocols: Management of toxoplasma uveitis generally involves antimicrobial therapy combined with anti-inflammatory medications. Common treatments include anti-parasitic agents such as pyrimethamine, sulfadiazine, or clindamycin, often accompanied by folinic acid. Corticosteroids are used to reduce inflammation and edema but are typically administered with caution to avoid exacerbating the infection. Regular monitoring is essential to assess response to treatment and prevent complications. In certain cases, surgical intervention may be necessary to manage complications like retinal detachment or significant scarring.
Clinical Advice & FAQs
Billing Guidance
Is B58.09 a billable ICD-10 code?
Yes, B58.09 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B58.09?
Clinical documentation must specify the nature of Other toxoplasma oculopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
